查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1589706

電子給藥系統市場：按類型、適應症、分銷管道分類 - 全球預測 2025-2030 年

Electronic Drug Delivery System Market by Type (Electronic Autoinjectors, Electronic Inhalers, Electronic Injection Pens), Indication (Asthma & COPD, Cardiovascular Disease, Diabetes), Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

電子給藥系統市場2023年估值為113.5億美元，預計到2024年將達到125.6億美元，複合年成長率為11.43%，預計到2030年將達到242.2億美元。

電子藥物輸送系統 (EDDS) 代表了醫療保健領域的一種變革性方法，它透過整合電子和藥物傳輸機制來最佳化準確性、計時和患者依從性。 EDDS 的範圍和定義涵蓋了廣泛的設備，例如輸液幫浦、自動注射器和吸入器，它們利用電子元件來提高給藥的準確性和有效性。對 EDDS 的需求源於對患者特定用藥方案的需求不斷增加、提高依從性的需要以及慢性疾病的擴散，其中精確的藥物傳遞至關重要。 EDDS 的應用涵蓋許多治療領域，包括糖尿病、疼痛管理、腫瘤學和神經病學，最終用途遍及醫院、居家醫療機構和專科診所。根據市場洞察，技術進步和對微創設備不斷成長的需求是成長的主要影響因素。此外，老年人口的成長和個人化醫療的推動提供了巨大的潛在機會。抓住這些機會的建議包括投資研發以提高設備連接性和易用性，以及新興國家的打入市場策略。然而，高成本、嚴格的監管核准以及潛在的網路安全威脅等限制因素給市場擴張帶來了挑戰。克服這些挑戰需要明確關注降低成本、合規性和強力的網路安全措施。創新和研究成熟的領域之一是人工智慧 (AI) 和物聯網的整合，以增強即時資料分析並改進設備功能。 EDDS 市場的特點是技術快速發展和競爭壓力，需要不斷創新和策略夥伴關係才能實現永續成長。總之，對於希望在不斷發展的 EDDS 環境中發展的公司來說，在應對成本和監管環境挑戰的同時擁抱技術整合至關重要。

主要市場統計
基準年[2023] 113.5億美元
預測年份 [2024] 125.6億美元
預測年份 [2030] 242.2億美元
複合年成長率（%） 11.43%

市場動態：快速發展的電子給藥系統市場的關鍵市場洞察

供需的動態交互作用正在改變電子給藥系統市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 目標疾病盛行率增加
    • 主要市場有利的贖回情況
    • 技術和設計的進步
  • 市場限制因素
    • 對替代藥物傳遞方法的偏好和潛在的錯誤
  • 市場機會
    • 對生技藥品和單株抗體的需求增加
    • 新興市場的成長機會
  • 市場挑戰
    • 新興國家不利的報銷結構

波特五力策略工具引領電子給藥系統市場

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解電子給藥系統市場的外部影響

外部宏觀環境因素在塑造電子給藥系統市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解電子給藥系統市場的競爭格局

對電子藥物輸送系統市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來發現自己的競爭定位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣電子給藥系統市場供應商的績效評估

FPNV 定位矩陣是評估電子給藥系統市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

制定電子給藥系統市場成功之路的策略分析與建議

對於旨在加強在全球市場的影響力的公司來說，對電子藥物輸送系統市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 擴大目標疾病的傳播
      • 主要市場有利的贖回情況
      • 技術和設計的進步
    • 抑制因素
      • 對替代藥物傳遞方法的偏好和潛在的錯誤
    • 機會
      • 對生技藥品和單株抗體的需求增加
      • 新興市場的成長機會
    • 任務
      • 新興國家不利的報銷結構
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章電子給藥系統市場：依類型

  • 電子自動注射器
  • 電子吸入器
  • 電子注射筆
  • 穿戴式電子輸液泵

第7章電子給藥系統市場（依適應症）

  • 氣喘及慢性阻塞性肺病
  • 心血管疾病
  • 糖尿病
  • 多發性硬化症

第8章電子給藥系統市場：按分銷管道

  • 醫院藥房
  • 網路藥房
  • 零售藥房

第9章美洲電子給藥系統市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區電子給藥系統市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲電子給藥系統市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Amgen, Inc.
  • Astrazeneca PLC
  • Bayer AG
  • Becton, Dickinson and Company
  • Cane SPA
  • Debiotech SA
  • F.Hoffmann-La Roche, Ltd.
  • Findair SP. Z OO
  • Insulet Corporation
  • Medtronic PLC
  • Merck Group
  • Novo Nordisk A/S
  • Tandem Diabetes Care, Inc.
  • United Therapeutics Corporation
  • Vicentra BV
Product Code: MRR-432CBFF6F300

The Electronic Drug Delivery System Market was valued at USD 11.35 billion in 2023, expected to reach USD 12.56 billion in 2024, and is projected to grow at a CAGR of 11.43%, to USD 24.22 billion by 2030.

The Electronic Drug Delivery System (EDDS) represents a transformative approach in health care by integrating electronics with drug delivery mechanisms to optimize precision, timing, and patient compliance. The scope and definition of EDDS encompass a wide range of devices including infusion pumps, autoinjectors, and inhalers that utilize electronic components to improve accuracy and efficacy in drug administration. The necessity of EDDS arises from the increasing demand for patient-specific medication regimes, the need for improved compliance, and the burgeoning prevalence of chronic diseases where precise drug delivery is crucial. Applications of EDDS span across numerous therapeutic areas such as diabetes, pain management, oncology, and neurology, with end-use distributed among hospitals, home care settings, and specialty clinics. Market insights reveal that technological advancements and the rising demand for minimally invasive devices are key influencing factors for growth. Furthermore, the increasing geriatric population and the push towards personalized medicine offer significant potential opportunities. Recommendation for grabbing these opportunities includes investment in R&D to enhance device connectivity and usability while strategizing market entry in emerging economies. However, limitations such as high costs, stringent regulatory approvals, and potential cybersecurity threats pose challenges to market expansion. Navigating these challenges requires clear focus on cost reduction, regulatory compliance, and robust cybersecurity measures. One area ripe for innovation and research is the integration of artificial intelligence (AI) and IoT in enhancing real-time data analytics and improving device functionality. The nature of the EDDS market is characterized by rapid technological evolution and competitive pressures, requiring constant innovation and strategic partnerships for sustained growth. In conclusion, embracing technological integration while addressing cost and regulatory challenges is pivotal for businesses aiming to achieve growth in the evolving EDDS landscape.

KEY MARKET STATISTICS
Base Year [2023] USD 11.35 billion
Estimated Year [2024] USD 12.56 billion
Forecast Year [2030] USD 24.22 billion
CAGR (%) 11.43%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Electronic Drug Delivery System Market

The Electronic Drug Delivery System Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing prevalence of target diseases
    • Favorable reimbursement scenario in major markets
    • Advancements in technologies and designs
  • Market Restraints
    • Preference for alternative drug delivery methods and the probability of errors
  • Market Opportunities
    • Increasing demand for biologics and Mabs
    • Growth opportunities in emerging markets
  • Market Challenges
    • Unfavorable reimbursement structure in developing countries

Porter's Five Forces: A Strategic Tool for Navigating the Electronic Drug Delivery System Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Electronic Drug Delivery System Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Electronic Drug Delivery System Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Electronic Drug Delivery System Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Electronic Drug Delivery System Market

A detailed market share analysis in the Electronic Drug Delivery System Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Electronic Drug Delivery System Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Electronic Drug Delivery System Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Electronic Drug Delivery System Market

A strategic analysis of the Electronic Drug Delivery System Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Electronic Drug Delivery System Market, highlighting leading vendors and their innovative profiles. These include Amgen, Inc., Astrazeneca PLC, Bayer AG, Becton, Dickinson and Company, Cane SPA, Debiotech S.A., F.Hoffmann-La Roche, Ltd., Findair SP. Z O. O., Insulet Corporation, Medtronic PLC, Merck Group, Novo Nordisk A/S, Tandem Diabetes Care, Inc., United Therapeutics Corporation, and Vicentra B.V..

Market Segmentation & Coverage

This research report categorizes the Electronic Drug Delivery System Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Electronic Autoinjectors, Electronic Inhalers, Electronic Injection Pens, and Electronic Wearable Infusion Pumps.
  • Based on Indication, market is studied across Asthma & COPD, Cardiovascular Disease, Diabetes, and Multiple Sclerosis.
  • Based on Distribution Channel, market is studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of target diseases
      • 5.1.1.2. Favorable reimbursement scenario in major markets
      • 5.1.1.3. Advancements in technologies and designs
    • 5.1.2. Restraints
      • 5.1.2.1. Preference for alternative drug delivery methods and the probability of errors
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing demand for biologics and Mabs
      • 5.1.3.2. Growth opportunities in emerging markets
    • 5.1.4. Challenges
      • 5.1.4.1. Unfavorable reimbursement structure in developing countries
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Electronic Drug Delivery System Market, by Type

  • 6.1. Introduction
  • 6.2. Electronic Autoinjectors
  • 6.3. Electronic Inhalers
  • 6.4. Electronic Injection Pens
  • 6.5. Electronic Wearable Infusion Pumps

7. Electronic Drug Delivery System Market, by Indication

  • 7.1. Introduction
  • 7.2. Asthma & COPD
  • 7.3. Cardiovascular Disease
  • 7.4. Diabetes
  • 7.5. Multiple Sclerosis

8. Electronic Drug Delivery System Market, by Distribution Channel

  • 8.1. Introduction
  • 8.2. Hospital Pharmacies
  • 8.3. Online Pharmacies
  • 8.4. Retail Pharmacies

9. Americas Electronic Drug Delivery System Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Electronic Drug Delivery System Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Electronic Drug Delivery System Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Amgen, Inc.
  • 2. Astrazeneca PLC
  • 3. Bayer AG
  • 4. Becton, Dickinson and Company
  • 5. Cane SPA
  • 6. Debiotech S.A.
  • 7. F.Hoffmann-La Roche, Ltd.
  • 8. Findair SP. Z O. O.
  • 9. Insulet Corporation
  • 10. Medtronic PLC
  • 11. Merck Group
  • 12. Novo Nordisk A/S
  • 13. Tandem Diabetes Care, Inc.
  • 14. United Therapeutics Corporation
  • 15. Vicentra B.V.

LIST OF FIGURES

  • FIGURE 1. ELECTRONIC DRUG DELIVERY SYSTEM MARKET RESEARCH PROCESS
  • FIGURE 2. ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ELECTRONIC DRUG DELIVERY SYSTEM MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. ELECTRONIC DRUG DELIVERY SYSTEM MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ELECTRONIC DRUG DELIVERY SYSTEM MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ELECTRONIC DRUG DELIVERY SYSTEM MARKET DYNAMICS
  • TABLE 7. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC AUTOINJECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC INHALERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC INJECTION PENS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC WEARABLE INFUSION PUMPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ASTHMA & COPD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 148. ELECTRONIC DRUG DELIVERY SYSTEM MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 149. ELECTRONIC DRUG DELIVERY SYSTEM MARKET, FPNV POSITIONING MATRIX, 2023